text:
EX-99
2
exhibit99-1.htm
EXHIBIT 99-1
Klondex Mines Ltd. - Exhibit 99.1 - Filed by newsfilecorp.com
2018-16
NEWS RELEASE
HECLA COMPLETES ACQUSITION OF KLONDEX MINES LTD.
FOR IMMEDIATE RELEASE
July 23, 2018
COEUR D'ALENE, IDAHO and
VANCOUVER, BC -- Hecla Mining Company (
NYSE:HL
) (Hecla) and Klondex Mines
Ltd. (NYSE American:KLDX; TSX:KDX) (Klondex) today announced that Hecla's
acquisition of Klondex is complete.
"With this acquisition, Hecla now
has three high-grade mines in Nevada, one of the best mining districts in the
world", said Phillips S. Baker, Jr., President and CEO. "These assets
immediately add production and cash flow, and because they are a good fit with
Hecla's expertise, we believe there is significant opportunity for improvement
in the mines' productivity and consistency." "We welcome the former Klondex
shareholders and employees to Hecla, as we continue to grow into the largest and
strongest Company in its long history", Mr. Baker added.
Hecla acquired the outstanding
common shares of Klondex for approximately US$153 million and 75 million shares
of Hecla common stock extinguishing all rights to acquire Klondex common shares.
Klondex shareholders who elected to receive share consideration will receive
0.6272 of a Hecla share in exchange for their Klondex shares. Klondex
shareholders who elected to receive combined cash and share consideration or who
failed to file an election on a timely basis will receive the combination
consideration of US$0.8411 in cash and 0.4136 of a Hecla share in exchange for
their Klondex shares. Klondex shareholders who elected to receive cash
consideration were subject to proration and will receive US$0.8867 in cash and
0.4020 of a Hecla share in exchange for their Klondex shares. Klondex
shareholders will also receive 0.125 of a common share of Havilah Mining
Corporation (Havilah), a newly-formed entity that will retain Klondex's Canadian
operations, as part of the consideration received in exchange for each of their
Klondex shares.
Havilah has been approved to list
its common shares on the TSX Venture Exchange, with trading expected to commence
at market open on July 25, 2018. Klondex has also received approval to delist
its common shares from the Toronto Stock Exchange, expected to occur at the
opening of trading on or about July 25, 2018. Klondex shares are expected to be
delisted from the NYSE American Stock Exchange prior to the opening of trading
on July 23, 2018.
As part of the transaction, Hecla
subscribed for 3,539,332 common shares of Havilah, on a private placement basis
at a price of C$2.61 per share for a gross purchase price of C$9,242,800 (being
the Canadian dollar equivalent of US$7 million). The shares of Havilah acquired
by Hecla represent 13.46% of the outstanding common shares of Havilah, after
giving effect to the subscription. The common shares were acquired for
investment purposes by Hecla. Hecla does not have any present intention to
acquire ownership of, or control over, additional securities of Havilah. It is
the intention of Hecla to evaluate its investment in Havilah on a continuing
basis and such holdings may be increased or decreased in the future. For the
purposes of Canadian National Instrument 62-103, the address of Hecla is 6500 N.
Mineral Drive, Suite 200, Coeur d'Alene, Idaho, 83815, USA.
Hecla Mining Company. 1-800-432-5291.
hmc-
info@hecla
-mining.com
1
ABOUT HECLA
Founded in 1891,
Hecla Mining Company (
NYSE:HL
) is a leading low-cost U.S. silver
producer with operating mines in Alaska, Idaho and Mexico, and is a growing gold
producer with operating mines in Quebec and Nevada. The Company also has
exploration and pre-development properties in eight world-class silver and gold
mining districts in the U.S., Canada, and Mexico.
Cautionary Statements Regarding Forward Looking Statements
Statements made or information
provided in this news release that are not historical facts are "forward-looking
statements" within the meaning of the Private Securities Litigation Reform Act
of 1995 and "forward-looking information" within the meaning of Canadian
securities laws. Words such as "may", "will", "should", "expects", "intends",
"projects", "believes", "estimates", "targets", "anticipates" and similar
expressions are used to identify these forward-looking statements. Such
forward-looking statements or forward-looking information include statements or
information regarding estimates of gold production, revenue, and mine life for
Fire Creek, Midas and Hollister, as well as statements concerning the combined
company's cash flow and profitability. The material factors or assumptions used
to develop such forward-looking statements or forward-looking information
include that the Company's plans for development and production will proceed as
expected and will not require revision as a result of risks or uncertainties,
whether known, unknown or unanticipated, to which the Company's operations are
subject.
Forward-looking statements
involve a number of risks and uncertainties that could cause actual results to
differ materially from those projected, anticipated, expected or implied. These
risks and uncertainties include, but are not limited to, metals price
volatility, volatility of metals production and costs, litigation, regulatory
and environmental risks, operating risks, project development risks, political
risks, labor issues, ability to raise financing and exploration risks and
results. Refer to the Company's Form 10K and 10-Q reports for a more detailed
discussion of factors that may impact expected future results. The Company
undertakes no obligation and has no intention of updating forward-looking
statements other than as may be required by law.
For further information, please contact:
Mike Westerlund Vice President - Investor Relations
800-HECLA91 (800-432-5291)
Investor Relations
Email: hmc-info@hecla-mining.com
Website:
www.hecla-mining.com
Hecla Mining Company. 1-800-432-5291.
hmc-
info@hecla
-mining.com
2

text: Klondex Mines Ltd.

text: HECLA

text: KLONDEX MINES LTD.

text: Hecla Mining Company

text: Hecla

text:
Klondex Mines
Ltd.

text: Klondex

text: Hecla

text: Klondex

text: Hecla

text: Hecla

text: Klondex

text: Hecla

text: Hecla

text: Klondex

text: Hecla

text: Klondex

text: Klondex

text: Hecla

text: Klondex

text: Klondex

text: Hecla

text: Klondex

text: Klondex

text: Hecla

text: Klondex

text: Klondex

text: Havilah

text: Havilah

text: Klondex

text: Klondex

text: Havilah

text: Klondex

text: Klondex

text: Hecla

text: Havilah

text: Havilah

text: Hecla

text: Havilah

text: Hecla

text: Hecla

text: Havilah

text: Hecla

text: Havilah

text: Hecla

text: Hecla Mining Company

text: HECLA

text: Hecla Mining Company

text: Mike Westerlund

text: Hecla Mining Company


dataset: buster

text:
EX-99.1 CHARTER
2
pr_07182012.htm
PRESS RELEASE DATED JULY 18, 2012
pr_07182012.htm
NEWS RELEASE
WEBTRADEX INTERNATIONAL CORP. ANNOUNCES ACQUISITION OF BWISHED FROM BIRTHDAY SLAM CORPORATION
Toronto, July 18, 2012
- Webtradex International Corp. (OTCBB: ZDVN) ("The Company" "Webtradex") is pleased to announce that it has completed acquisition of certain assets of Birthday Slam Corporation, an Ontario Corporation ("BSC")
Under an asset purchase agreement closed on July 17, 2012, the Company acquired, from BSC, all intellectual property related to the development of B'Wished, currently being developed and financed by BSC. All related URLs, design, concept and software codes are included in the purchase. Webtradex will assume the cost of financing going forward. B'Wished is expected to launch at the beginning of September 2012.The total purchase price is $325,000 payable by a secured note, bearing a 5 % interest rate. The Company also assumed, as part of the purchase price, three BSC loans totaling $ 60,000 from non-related parties to be settled by the issuance of 400,000 restricted common shares of the
Company.
As part of the transaction, Webtradex has assumed an ownership interest of 2.38 % of Huubla, a privately held Copenhagen based, Internet Company.
Jeff Coe, the chief operating officer, commented: "The social shopping sector is one of the hottest growth markets in the internet space. The future of ecommerce, search and social marketing is now tied to personality-influenced consumer procuration. By combining the teams of Webtradex and B'wished, and the synergies that exist between them, I expect us to become a forerunner and a major player in the social ecommerce sector".
About the Company
Webtradex International Corporation is seeking to expand into the internet industry by acquiring and supporting emerging internet-related technologies and other related assets.
For further information regarding this press release, investment opportunities, or other questions, please contact Jeff Robinson at
jeff.robinson@webtradex.com
phone:
+34 600 115 789
Please visit our website at www.webtradex.com for more corporate information.
Forward-Looking Statements
This press release includes forward-looking statements that involve risks and uncertainties. Forward-looking statements are statements that are not historical facts. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ from the forward-looking statements. The Company expressly disclaims any obligation to publicly update any forward-looking statements contained herein, whether as a results of new information, future events or otherwise, except as required by law.

label: organization

text: WEBTRADEX INTERNATIONAL CORP.

text: BWISHED

text: BIRTHDAY SLAM CORPORATION

text: Webtradex International Corp.

text: Webtradex

text: Birthday Slam Corporation

text: Webtradex

text: Webtradex

text: Webtradex

source_dataset: expertai/BUSTER

annotation_scope: BUSTER company-role spans plus reviewed organization, fund, person, and event additions with document-local surface projection; annotations remain non-exhaustive


text:
EX-99.1
3
ex99-1.htm
EXHIBIT 99.1
ex99-1.htm
Exhibit 99.1
Contact:
Primo Water Corporation
Mark Castaneda, Chief Financial Officer
(336) 331-4000
ICR Inc.
Katie Turner
Hunter Wells
(646) 277-1228
Primo Water Completes Strategic Acquisition of Glacier Water Services, Inc.
WINSTON-SALEM, N.C. December 12, 2016 -- Primo Water Corporation (Nasdaq: PRMW), the leading provider of multi-gallon purified bottled water, self-service refill water and water dispensers, announced that effective today it has completed the acquisition of Glacier Water Services, Inc., for approximately $273 million.
"The completion of this acquisition is an exciting step forward. We welcome the Glacier team to the Primo family as we unite two highly-complementary businesses to create significant benefits for our customers and retail partners", said Billy D. Prim, Primo's Chairman and Chief Executive Officer. "The opportunity to expand our portfolio of high-quality water and water dispenser offerings should better position us to diversify our sales channels, create operational synergies, and drive sales, cash flow and profit growth".
The completion of this transaction adds a talented group of executives to Primo, with tenured backgrounds and proven track records. Effective today, and as previously announced, Brian McInerney, CEO of Glacier Water, and key management will operate the combined refill businesses, reflecting their commitment to the future success of the combined company. In addition, Charles Norris, Chairman of the Board of Directors of Glacier Water, will join Primo Water's Board, expanding the board from seven to eight members, effective today.
The total transaction consideration included approximately $50 million in cash, approximately $36 million in Primo common stock, the assumption or retirement of approximately $177 million of net indebtedness and preferred stock, and five-year warrants to purchase 2.0 million shares of Primo's common stock at an exercise price of $11.88 per share. The assumed indebtedness includes Glacier's trust preferred securities due in 2028, which will remain outstanding. Primo financed the transaction with proceeds from a new $196 million senior credit facility consisting of a five-year revolver and term loan with minimal amortization requirements.
Financial Modeling Conference Call and Webcast
Primo Water will host a conference call to provide financial modeling information on the Glacier Water acquisition and review its outlook for the combined Company at 10:00 a.m. ET on Monday, January 9, 2017. Participants from the Company will be Billy D. Prim, Chief Executive Officer, Matt Sheehan, President and Chief Operating Officer, and Mark Castaneda, Chief Financial Officer. The conference call and accompanying presentation slides will be webcast live at the Investor Relation section of Primo Water's website at www.primowater.com and will be archived online for playback for a period of two weeks following the call. In addition, for the live broadcast listeners may dial (877) 407-0784 in North America, and international listeners may dial (201) 689-8560.
About Primo Water Corporation
Primo Water Corporation (Nasdaq: PRMW) is North America's leading single source provider of multi-gallon purified bottled water, self-service refill water and water dispensers sold through major retailers throughout the United States and Canada. For more information and to learn more about Primo Water, please visit our website at www.primowater.com.
About Glacier Water Services, Inc.
Glacier is the leading provider of high-quality drinking water dispensed to consumers through self-service water machines located at supermarkets and other retail locations. For more information, visit www.glacierwater.com.
Forward-Looking Statements
Certain statements contained herein are not based on historical fact and are "forward-looking statements" within the meaning of the applicable securities laws and regulations. These statements include the expected benefits to the Company from the completion of the acquisition, the combined company's commitment to and ability to repay debt and reduce leverage and the Company's financial guidance on a stand-alone basis for 2016. These statements can otherwise be identified by the use of words such as "anticipate", "believe", "could", "estimate", "expect", "feel", "forecast", "intend", "may", "plan", "potential", "project", "should", "would", "will", and similar expressions intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. These statements are subject to a number of risks and uncertainties.
Factors that could cause actual results to differ include, amount other things, difficulties with the successful integration and realization of the anticipated benefits from the acquisition, the possibility that the Company's stock price may be affected after the acquisition by factors different than those previously affecting the Company's stock price, the incurrence of costs related to the acquisition, changes to the Company's board of directors and management in connection with the acquisition, the impact of the loss or non-retention of certain key personnel as a result of the acquisition or thereafter, the termination or renegotiation of agreements with customers, suppliers and other business partners in connection with the acquisition, the possibility that the Company's financial results following the acquisition may differ materially from the unaudited pro forma financial statements that have been or will be made available, any possible adverse impacts related to the implementation and integration of proper and effective internal controls in the combined company following the acquisition, general economic conditions the possible adverse impacts that decreased discretionary consumer and corporate spending may have on the Company's business, the possible adverse impacts of currently pending or future litigation proceedings and the Company's need for additional capital following the acquisition.
Owing to the uncertainties inherent in forward-looking statements, actual results could differ materially and adversely from those stated herein.
This release also includes such other factors that could cause actual results to differ materially and adversely from those in the forward-looking statements and include, but are not limited to, adverse changes in the Company's relationships with its independent bottlers, distributors and suppliers, the loss of major retail customers of the Company or the reduction in volume or change in timing of purchases by major retail customers, lower than anticipated consumer and retailer acceptance of and demand for the Company's products and services, the entry of a competitor with greater resources into the marketplace, competition and other business conditions in the water and water dispenser industries in general, the Company's experiencing product liability, product recall or higher than anticipated rates of sales returns associated with product quality or safety issues, the loss of key Company personnel, changes in the regulatory framework governing the Company's business, the Company's inability to efficiently expand operations and capacity to meet growth, the Company's inability to develop, introduce and produce new product offerings within the anticipated timeframe or at all, the Company's inability to comply with its covenants in its credit facility, significant liabilities or costs associated with litigation or other legal proceedings, as well as other risks described more fully in the Company's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K filed on March 9, 2016 and its subsequent filings under the Securities Exchange Act of 1934. Forward-looking statements reflect management's analysis as of the date of this release. The Company does not undertake to revise these statements to reflect subsequent developments, other than in its regular, quarterly earnings releases or as otherwise required by applicable securities laws.

text: Primo Water Corporation

label: person

text: Mark Castaneda

text: Primo Water

text: Glacier Water Services, Inc.

text: Primo Water Corporation

text: Glacier Water Services, Inc.

text: Billy D. Prim

text: Charles Norris

text: Primo Water

text: Primo Water

text: Billy D. Prim

text: Matt Sheehan

text: Mark Castaneda

text: Primo Water

text: Primo Water Corporation

text: Primo Water Corporation

text: Primo Water

text: Glacier Water Services, Inc.


text:
EX-99
4
pr040105.txt
PRESS RELEASE DATED APRIL 1, 2005
FOR IMMEDIATE RELEASE
Contact: Ross A Benavides
Chief Financial Officer
(713)860-2528
GENESIS ENERGY, L.P. ACQUIRES SYNGAS PARTNERSHIP INTEREST
April 1, 2005 - Genesis Energy, L.P. (AMEX:GEL) announced today that,
through its wholly owned subsidiary, Genesis Syngas Investments, L.P., it has
completed its previously announced acquisition of the 50% partnership interest
in T&P Syngas Supply Company ("T&P Syngas") from TCHI Inc.("TCHI"), a wholly
owned subsidiary of ChevronTexaco Global Energy Inc. for $13.5 million. The
acquisition was subject to a right of first refusal held by Praxair Hydrogen
Supply Inc. ("Praxair") which holds the other 50% partnership interest in T&P
Syngas. Praxair waived its option to purchase the 50% interest in T&P Syngas
currently held by TCHI.
T&P Syngas is a partnership that owns a syngas manufacturing facility
(the "Facility") located in Texas City, Texas. The Facility processes natural
gas to produce syngas (a combination of carbon monoxide and hydrogen) and high
pressure steam. All of the syngas and steam produced by the Facility is sold to
Praxair under a long-term processing agreement.
Based on currently available information, Genesis expects the
transaction to be immediately accretive to distributable cash flow and to
generate approximately $1.0 million of additional net cash provided by operating
activities during the first year of operation. The acquisition will be financed
through Genesis' credit facility with Bank of America.
Genesis Energy, L.P., operates crude oil common carrier pipelines and
is an independent gatherer and marketer of crude oil and natural gas in North
America, with operations concentrated in Texas, Louisiana, Alabama, Florida, and
Mississippi. Genesis Energy, L.P. also operates a wholesale CO2 marketing
business.
This press release includes forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933 and Section 21E of the
Securities Exchange Act of 1934. Although Genesis believes that its expectations
are based upon reasonable assumptions, it can give no assurance that its goals
will be achieved. Important factors that could cause actual results to differ
materially from those in the forward looking statements herein include the
timing and extent of changes in commodity prices for oil, ability to obtain
adequate credit facilities, environmental risks, government regulation, the
ability of the Company to meet its stated business goals and other risks noted
from time to time in the Company's Securities and Exchange Commission filings.
# # #

text: GENESIS ENERGY, L.P.

text: Genesis Energy, L.P.

text: TCHI Inc.

text: Genesis Energy, L.P.

text: Genesis Energy, L.P.


text:
EX-99.1
2
rrd99534_10175.htm
PRESS RELEASE DATED DECEMBER 8, 2005
Exhibit 99.1
OXIS INTERNATIONAL ACQUIRES MAJORITY STAKE IN BIOCHECK, A LEADING MANUFACTURER OF IMMUNOASSAY KITS
Acquisition Expands Product Portfolio and Drives Growth Opportunities for New Products in Cardiac Risk Assessment and Custom Assay Development
PORTLAND, Ore. -- December 8, 2005 -- OXIS International, Inc. (OTCBB: OXIS.OB) (Nouveau Marché: OXIS) (FWB: OXI), specialists in developing technologies for the diagnosis of diseases resulting from oxidative stress, announced today the initial closing of its acquisition of BioCheck, Inc., a leading producer of enzyme immunoassay kits.
As previously announced, OXIS has agreed to acquire up to all of the outstanding shares of BioCheck for an aggregate purchase price of $6 million in cash. In this initial closing, OXIS has purchased fifty-one percent (51%) of the outstanding shares of BioCheck for $3,060,000 in cash.
In addition, the two companies plan to enter into a services agreement whereby OXIS would deliver primarily operating, sales, marketing and business development functions while BioCheck would provide manufacturing and research and development expertise.
"We are excited about the potential synergies resulting from the combination of the core competencies of OXIS and BioCheck", stated OXIS CEO Steve Guillen. "The expanded product portfolio will allow us to strengthen our position in the growing clinical diagnostics market, and the manufacturing and sales efficiencies derived from the consolidation of operations should help drive future margin expansion for the combined entity".
The potential synergies that may increase BioCheck's contribution to OXIS' efforts towards achieving margin expansion include:
Highly complementary and experienced management team combining the successful emerging biotechnology commercialization track record of OXIS CEO Steve Guillen and the scientific and operational management experience of BioCheck CEO Dr. John Chen;
Complementary technologies in promising area of cardiac risk assessment: BioCheck manufactures ELISA (Enzyme-Linked Immunosorbent Assay) tests using Troponin I, Myoglobin, and C-Reactive Protein biomarkers for the evaluation of acute myocardial infarction (AMI) while OXIS is developing a series of ELISA cardiac tests involving Myeloperoxidase (MPO) & Glutathione Peroxidase (GPx) used to help predict early cardiac risk;
BioCheck's extensive experience in the growing contract services sector, including custom immunoassay development, antibody purification and conjugation, and contract assembly;
Increased production capacity, primarily for the ELISA kits, allowing for reduced dependence on third party manufacturing and reduced production costs;
Operating and cost efficiencies deriving from the consolidation of several aspects of the companies' respective manufacturing and commercial distribution bases, such as promotional and marketing costs;
BioCheck's current Good Manufacturing Practices (cGMP) and ISO quality certification for the combined companies' manufacturing facilities;
"We believe that growth opportunities in the market segments that our companies jointly serve are substantial", stated BioCheck CEO Dr. John Chen. "By combining our resources and expertise we expect to be able to lead a new generation of breakthrough assays, particularly in the area of cardiac predictors, as well as custom immunoassay development and other contract services".
BioCheck currently offers over 45 enzyme immunoassays as well as research and manufacturing services focused on the immunoassay products. At year-end 2005, BioCheck expects to be profitable with revenues in excess of $4.5 million. In addition, the company has the commercialization rights for several promising new cancer/tumor biomarkers.
As part of the acquisition's successful first closing, OXIS has initiated plans to close its non-core facility in Portland, OR and merge its core operations with BioCheck's GMP and ISO quality certified facilities in Northern California.
About OXIS
OXIS International, Inc., headquartered in Portland, Oregon, focuses on developing technologies and products to research, diagnose, treat and prevent diseases associated with damage from free radical and reactive oxygen species -- diseases of oxidative stress. The company holds the rights to three therapeutic classes of compounds in the area of oxidative stress, and develops, manufactures and markets products and technologies to diagnose and treat diseases caused by oxidative stress.
More information about OXIS and its products and services, as well as current SEC filings, may be obtained by visiting the Company's Web site at http://www.oxis.com.
About BioCheck
BioCheck, Inc. operates a 15,000 square-foot, U.S. Food and Drug Administration (FDA) certified cGMP device-manufacturing facility in Foster City, California. The company is a leading producer of high quality enzyme immunoassay research services and products offering immunoassay kits for a wide variety of classifications including cardiac markers, tumor markers, infectious diseases, thyroid function, steroids, and fertility hormones (http://www.biocheckinc.com).
Statements in this release that are not purely historical are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including, without limitation, any statements regarding beliefs, plans, estimates, projections, expectations, goals or intentions regarding the future. Forward-looking statements in this release include statements regarding (i) the acquisition expanding OXIS' product portfolio and offering growth opportunities in cardiac risk assessment and custom assay development; (ii) potential synergies of the combined company; (iii) the consummation of the merger of OXIS and Bio Check; (iv) BioCheck revenues exceeding $4.5 million and BioCheck being profitable for the year ending December 31, 2005; (v) the combined company's management team providing extensive experience in the commercialization of emerging technologies and scientific and operational management; (vi) the expanded product portfolio strengthening the combined company's position in the growing clinical diagnostics market; (vii) the manufacturing and sales efficiencies derived from the consolidation of operations driving margin expansion; (viii) the complementary technologies in the area of cardiac risk assessment; (ix) operating and cost efficiencies derived from the consolidation of several aspects of the combined company's manufacturing and commercial distribution bases;(x) increased production capacity, primarily for the ELISA tests, allowing for reduced dependence on third party manufacturing and reduced production costs; (xi) growth opportunities in the market segments that the companies jointly serve; (xii) by combining resources and expertise the combined company leading a new generation of breakthrough assays, particularly in the area of cardiac predictors, as well as custom immunoassay development and other contract services; and (xiii) OXIS plans to close its non-core facility in Portland, OR and merge its core operations with BioCheck's GMP and ISO quality certified facilities in Northern California. Factors that could cause actual results to differ materially from the forward-looking statements include risks and uncertainties such as the acquisition of the remaining 49% of the BioCheck shares by OXIS not closing due to, among other reasons, the inability of OXIS to close a financing transaction; the risks inherent in integrating an acquired business; risks inherent in owning a majority interest in a company; unforeseen difficulties in achieving synergies following an acquisition; unforeseen difficulties related to the company's oxidative stress and other diagnostic products; the development by the company's competitors of new competing products; and other risks indicated in the company's filings with the Securities and Exchange Commission. It is important to note that actual outcomes could differ materially from those in such forward-looking statements. Readers should also refer to the documents filed by the company with the Securities and Exchange Commission, specifically the annual report on Form 10-KSB for the year ended December 31, 2004, filed with the Securities and Exchange Commission on February 25, 2005, and the company's quarterly report on Form 10-QSB filed with the Securities and Exchange Commission on November 14, 2005.
# # #
Investor Contact:
Steve Guillen President & CEO
OXIS International Tel: (503)247-2370 sguillen@oxis.com
Media Contacts:
Anna Gralinska
Deliberate Co.
Tel: (877)879-2994
annag@deliberatecompany.com
Carol Ruth The Ruth Group Tel: (646)536-7004 cruth@theruthgroup.com

text: OXIS INTERNATIONAL

text: BIOCHECK

text: OXIS International, Inc.

text: OXIS

text: BioCheck, Inc.

text: OXIS

text: BioCheck

text: OXIS

text: BioCheck

text: OXIS

text: BioCheck

text: OXIS

text: BioCheck

text: OXIS

text: Steve Guillen

text: BioCheck

text: OXIS

text: OXIS

text: Steve Guillen

text: BioCheck

text: John Chen

text: BioCheck

text: OXIS

text: BioCheck

text: BioCheck

text: BioCheck

text: John Chen

text: BioCheck

text: BioCheck

text: OXIS

text: BioCheck

text: OXIS

text: OXIS International, Inc.

text: OXIS

text: BioCheck

text: BioCheck, Inc.

text: OXIS

text: OXIS

text: BioCheck

text: BioCheck

text: OXIS

text: BioCheck

text: BioCheck

text: OXIS

text: OXIS

text: Steve Guillen

text: OXIS International


text:
EX-99.1
2
t1501462_ex99-1.htm
EXHIBIT 99.1
Exhibit 99.1
Press Release
FOR IMMEDIATE RELEASE
Contact:
Kevin M. O'Connor
President & CEO
(631) 537-1000
BRIDGE BANCORP, INC. COMPLETES ACQUISITION
OF COMMUNITY
NATIONAL BANK (CNB)
BNB Branch Network Expands to 40 Branches
from Montauk to Manhattan
(Bridgehampton, NY - June 22,
2015)
Bridge
Bancorp, Inc. (NASDAQ:BDGE), the holding company for Bridgehampton National Bank (BNB), today announced
it completed its acquisition of Community National Bank (CNB) as of the close of business on Friday, June 19, 2015, and converted
core systems to BNB over the weekend.
"This morning, eleven former CNB
branches reopened as fully operational BNB branches ready to deliver local, personal community banking services to business and
individual customers. I am proud of our team's hard work to make this happen quickly and smoothly", commented Kevin
M. O'Connor, President and CEO of Bridge Bancorp, Inc. "The acquisition of CNB expands the Bridgehampton National Bank
footprint across Long Island including Nassau and Queens and into NYC. As one of the largest Long Island based community banks,
our mission is to assist local businesses grow and expand, contributing to a vital Long Island economy", added Mr. O'Connor.
In connection with the closing of the transaction,
Bridge Bancorp, Inc. issued in the aggregate approximately 5.647 million shares of its common stock to CNB shareholders, at an
exchange ratio of.79 shares of BDGE for each share of CNB. Following the acquisition, Bridge Bancorp's assets are approximately
$3.2 billion, with loans of approximately $2.2 billion and deposits of $2.7 billion.
About Bridge Bancorp, Inc.
Bridge Bancorp, Inc. is a one bank holding
company engaged in commercial banking and financial services through its wholly owned subsidiary, The Bridgehampton National Bank
("BNB"). Established in 1910, BNB, with assets of approximately $3.2 billion, operates 40 retail branch locations serving
Long Island and the greater New York metropolitan area. In addition, the Bank operates two loan production offices: one in Manhattan,
and one in Riverhead, New York. Through its branch network and its electronic delivery channels, BNB provides deposit and loan
products and financial services to local businesses, consumers and municipalities. Title insurance services are offered through
BNB's wholly owned subsidiary, Bridge Abstract. Bridge Financial Services, Inc. offers financial
planning and investment consultation. For more information visit www.bridgenb.com.
BNB also has a rich tradition of involvement
in the community, supporting programs and initiatives that promote local business, the environment, education, healthcare, social
services and the arts.

text: BRIDGE BANCORP, INC.

text:
COMMUNITY
NATIONAL BANK (CNB)

text:
Bridge
Bancorp, Inc.

text: Community National Bank (CNB)

text: Bridge Bancorp, Inc.

text: Bridge Bancorp, Inc.

text: Bridge Bancorp

text: Bridge Bancorp, Inc.

text: Bridge Bancorp, Inc.

text: Bridge Financial Services, Inc.